UroGen Pharma URGN
NASDAQ URGN
$26.10 +0.78 (+3.08%)
At close: Nov 11, 2026 · 4:00 PM EST

UroGen Pharma (URGN) Change in Acquisitions & Divestments (2018 - 2019)

Updated

UroGen Pharma (URGN) recorded Change in Acquisitions & Divestments of -$35.9 million in FY2018, compared with $36 million in FY2017.

Analysis

UroGen Pharma (URGN) Change in Acquisitions & Divestments (2018 - 2019) Analysis & Trends

  • Per Business Quant data, URGN's Change in Acquisitions & Divestments was $36 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 UroGen Pharma 1.24 Bn 782.15 Mn 81.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -26.71 Mn
Mar 31, 2018 35.90 Mn
API Access

UroGen Pharma Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=URGN&period=max&api_key=YOUR_API_KEY